An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutics and Clinical Risk Management"
DOI: 10.2147/tcrm.s310371
Abstract: Abstract Pharmacologic treatment for overactive bladder (OAB), which is characterized by bothersome symptoms such as urgency and urge urinary incontinence (UUI), includes anticholinergics and β3-adrenergic receptor agonists. Anticholinergics are associated with adverse effects including dry… read more here.
Keywords: efficacy safety; treatment; safety vibegron; vibegron ... See more keywords